Pharma channel feed

Drug pric­ing ex­perts skep­ti­cal that Flori­da's drug im­port plan will work

Last year

GSK’s Vi­iV spon­sors new sea­son of Ru­Paul TV show to spark HIV pre­ven­tion con­ver­sa­tions

Last year
Marketing

Semaglu­tide as­so­ci­at­ed with low­er risk of sui­ci­dal ideations com­pared to non-GLP-1 drugs: NIH-fund­ed study

Last year

'If you could have the next Prozac, that’s in­tox­i­cat­ing': Sage’s post­par­tum de­pres­sion tri­umph and the fail­ure that fol­lowed

Last year
R&D
In Focus

No­var­tis adds In­di­anapo­lis site to its man­u­fac­tur­ing ca­pac­i­ty for ra­di­oli­gand drug Plu­vic­to

Last year
Manufacturing

IQVIA and Pro­pel aban­don merg­er af­ter FTC probe and in­junc­tion

Last year
Marketing

UCB de­parts in­dus­try trade group BIO, fol­low­ing Pfiz­er's ex­it late last year

Last year

Re­vance los­es at­tempt to dis­miss Botox trade se­crets law­suit

Last year
Law

FDA lifts par­tial clin­i­cal hold on In­nate's can­cer drug af­ter pa­tient death linked to dis­ease pro­gres­sion

Last year
FDA+

Lil­ly says its weight loss drugs Moun­jaro and Zep­bound should­n't be used for 'cos­met­ic' rea­sons

Last year
Marketing

Klick Health nabs award-win­ning cre­ative di­rec­tor Tim Jones to lead team in Eu­rope

Last year
Marketing

House Re­pub­li­cans call on FDA to hand over in­fo on in­ter­nal sci­en­tif­ic dis­agree­ments

Last year
FDA+

Eli Lil­ly jumps in­to di­rect-to-con­sumer weight loss are­na

Last year
Marketing
Health Tech

Roche pens third pact of the week in $66M up­front to MO­MA Ther­a­peu­tics

Last year
Startups
Deals

No­vo’s broad Flag­ship part­ner­ship starts with obe­si­ty at Omega and MASH at Cel­lar­i­ty

Last year
Startups
Deals

Dr. Red­dy's, Tor­rent Phar­ma and Lau­rus Syn­the­sis all land Form 483 let­ters fol­low­ing FDA in­spec­tions

Last year
FDA+
Manufacturing

Bausch + Lomb puts new spin on an­nu­al glau­co­ma cam­paign with a fo­cus on ‘Faces’

Last year
Marketing

GSK shrinks Scynex­is deal af­ter de­lay in com­mer­cial­iza­tion of an­ti­fun­gal drug

Last year
Deals
Manufacturing

Pfiz­er gene ther­a­py gets he­mo­phil­ia B ap­proval in Cana­da, set­ting stage for CSL ri­val­ry

Last year
Cell/Gene Tx
FDA+

Dai­ichi Sankyo set­tles its car­dio drug law­suit with Es­pe­ri­on, which will get $125M mile­stone pay­ment

Last year
Law

Biden ad­min­is­tra­tion to use De­fense Pro­duc­tion Act to tack­le drug short­ages

Last year
FDA+

Yale Law School's free speech group says Boehringer's IRA ar­gu­ment is 'fun­da­men­tal­ly flawed'

Last year
Law

Court grants FTC in­junc­tion over IQVI­A's deal with Pro­pel Me­dia and Deep­In­tent

Last year
Marketing

Bey­for­tus ap­proved in Chi­na to pro­tect in­fants from RSV; Il­lu­mi­na in­vestor files class ac­tion suit

Last year
First page Previous page 81828384858687 Next page Last page
A service from the Financial Times